QTRX
Quanterix CorpNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$126.72M
P/E Ratio
—
EPS
$-2.35
Beta
1.15
52W High
$8.77
52W Low
$2.40
50-Day MA
$3.40
200-Day MA
$5.28
Dividend Yield
—
Profit Margin
-71.90%
Forward P/E
—
PEG Ratio
—
About Quanterix Corp
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.
Fundamentals
| Revenue (TTM) | $144.98M |
| Gross Profit (TTM) | $65.69M |
| EBITDA | $-63.67M |
| Operating Margin | -59.10% |
| Return on Equity | -34.80% |
| Return on Assets | -13.40% |
| Revenue/Share (TTM) | $3.24 |
| Book Value | $6.00 |
| Price-to-Book | 0.45 |
| Price-to-Sales (TTM) | 0.87 |
| EV/Revenue | 0.434 |
| EV/EBITDA | -1.49 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 20.10% |
| Shares Outstanding | $47.11M |
| Float | $38.49M |
| % Insiders | 6.24% |
| % Institutions | 85.44% |
Historical Volatility
HV 10-Day
60.74%
HV 20-Day
91.16%
HV 30-Day
81.98%
HV 60-Day
72.89%
HV Rank
66.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($4.33 target)
3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026